Literature DB >> 15950903

Activation of RalA is critical for Ras-induced tumorigenesis of human cells.

Kian-Huat Lim1, Antonio T Baines, James J Fiordalisi, Michail Shipitsin, Larry A Feig, Adrienne D Cox, Channing J Der, Christopher M Counter.   

Abstract

RalGEFs were recently shown to be critical for Ras-mediated transformed and tumorigenic growth of human cells. We now show that the oncogenic activity of these proteins is propagated by activation of one RalGEF substrate, RalA, but blunted by another closely related substrate, RalB, and that the oncogenic signaling requires binding of the RalBP1 and exocyst subunit effector proteins. Knockdown of RalA expression impeded, if not abolished, the ability of human cancer cells to form tumors. RalA was also commonly activated in a panel of cell lines from pancreatic cancers, a disease characterized by activation of Ras. Activation of RalA signaling thus appears to be a critical step in Ras-induced transformation and tumorigenesis of human cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950903     DOI: 10.1016/j.ccr.2005.04.030

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  177 in total

1.  RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

Authors:  Vincent Neyraud; Vasily N Aushev; Anastassia Hatzoglou; Brigitte Meunier; Ilaria Cascone; Jacques Camonis
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 2.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

Review 3.  The Exocyst at a Glance.

Authors:  Bin Wu; Wei Guo
Journal:  J Cell Sci       Date:  2015-08-03       Impact factor: 5.285

Review 4.  Mitochondrial dynamics as regulators of cancer biology.

Authors:  Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

Review 5.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 6.  Inhibition of Ras for cancer treatment: the search continues.

Authors:  Antonio T Baines; Dapeng Xu; Channing J Der
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

7.  Pituitary somatolactotropes evade an oncogenic response to Ras.

Authors:  Allyson K Roof; Tammy Trudeau; Arthur Gutierrez-Hartmann
Journal:  Mol Cell Endocrinol       Date:  2018-05-09       Impact factor: 4.102

8.  A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.

Authors:  Thomas B Karasic; E Gabriela Chiorean; Said M Sebti; Peter J O'Dwyer
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

9.  RalA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling.

Authors:  Nagaraj Balasubramanian; Jeremy A Meier; David W Scott; Andrés Norambuena; Michael A White; Martin Alexander Schwartz
Journal:  Curr Biol       Date:  2009-12-10       Impact factor: 10.834

10.  GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer.

Authors:  Anna-Karin M Sjogren; Karin M E Andersson; Meng Liu; Briony A Cutts; Christin Karlsson; Annika M Wahlstrom; Martin Dalin; Carolyn Weinbaum; Patrick J Casey; Andrej Tarkowski; Birgitta Swolin; Stephen G Young; Martin O Bergo
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.